Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/135667
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review |
Author: | Minelli, A. Barlati, S. Baune, B.T. |
Citation: | European Neuropsychopharmacology, 2022; 59:68-81 |
Publisher: | Elsevier BV |
Issue Date: | 2022 |
ISSN: | 0924-977X 1873-7862 |
Statement of Responsibility: | Alessandra Minelli, Stefano Barlatic, Bernhard T Baunee, European College of Neuropsychopharmacology, ECNP, Pharmacogenomics, Transcriptomics Network |
Abstract: | Abstract not available |
Keywords: | Major depressive disorder; Randomized controlled trial; Remission |
Rights: | © 2022 Elsevier B.V. and ECNP. All rights reserved. |
DOI: | 10.1016/j.euroneuro.2022.04.007 |
Grant ID: | NHMRC |
Published version: | http://dx.doi.org/10.1016/j.euroneuro.2022.04.007 |
Appears in Collections: | Psychiatry publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.